Literature DB >> 6724838

Human retinal S-antigen. Isolation, purification, and characterization.

D A Beneski, L A Donoso, K E Edelberg, L E Magargal, R Folberg, C Merryman.   

Abstract

S-antigen, a highly pathogenic agent for the inducation of experimental autoimmune uveitis ( EAU ), was obtained in a pure state from human retina by conventional salt fractionation, molecular sieve and ion exchange chromatography. The physical and chemical properties of the purified protein including the molecular weight, isoelectric point and amino acid composition were determined. The physical properties of the purified human retinal S-antigen were similar, but not identical, to those previously reported for bovine retinal S-antigen (J Immunol 119:1949, 1977). Following the injection of 50 micrograms of human retinal S-antigen into the footpads of guinea pigs, EAU was documented both clinically and histopathologically. The relationship between S-antigen, uveitis, and the pineal gland is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724838

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Primitive pineal tumor with retinoblastomatous and retinal/ciliary epithelial differentiation: an immunohistochemical study.

Authors:  J Raisanen; H Vogel; D S Horoupian
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

2.  S-antigen immunoreactivity in human pineal glands and pineal parenchymal tumors. A monoclonal antibody study.

Authors:  E Perentes; L J Rubinstein; M M Herman; L A Donoso
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

3.  Anti-retinal S-antigen antibodies in human sera: a comparison of reactivity in ELISA with human or bovine S-antigen.

Authors:  G Doekes; L Luyendijk; M J Gerritsen; A Kijlstra
Journal:  Int Ophthalmol       Date:  1992-05       Impact factor: 2.031

4.  Retinal S-antigen immunoreactivity in medulloblastomas.

Authors:  J M Bonnin; E Perentes
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.